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ABSTRACT
Introduction This study aims to investigate whether the 
associations between impaired glucose regulation and 
health- related quality of life are modified by severity or 
type of depressive symptoms.
Research design and methods For this cross- sectional 
study, we included 1939 individuals (mean age 61.5 years) 
from the Helsinki Birth Cohort Study. Between 2001 and 
2004, a standard 2- hour 75 g oral glucose tolerance test 
was applied to define normoglycemia, pre- diabetes, and 
newly diagnosed diabetes. Information on previously 
diagnosed diabetes was collected from national registers 
and questionnaires. Pre- diabetes was defined as having 
either impaired fasting glucose or impaired glucose 
tolerance. The Mental and Physical Component Scores 
of health- related quality of life were assessed with Short 
Form-36. Beck’s Depression Inventory was employed to 
investigate the severity of depressive symptoms and to 
define minimal (depression score <10), non- melancholic, 
and melancholic types of depression. We analyzed data 
with general linear models adjusted for sex, age, lifestyle 
factors, comorbidities, and body mass index.
Results Glucose regulation subgroups, especially 
previously known diabetes, were associated with 
lower Physical Component Score (p=0.001) and higher 
depression score (p=0.015), but not with the Mental 
Component Score (p=0.189). Non- melancholic depression 
was associated with lower Physical and Mental Component 
Scores compared with those with depression score 
<10 and melancholic depression (p<0.001), independently 
of glucose regulation status (p for glucose regulation 
status by depression type interaction >0.54).
Conclusions Non- melancholic type of depression and 
previously known diabetes are independently associated 
with lower health- related quality of life. This should 
be appraised in long- term treatment of diabetes and 
when treating non- melancholic depressive symptoms to 
maintain a higher health- related quality of life.
INTRODUCTION
Globally, both type 2 diabetes and depres-
sion show a high and increasing prevalence. 
Diabetes is estimated to affect 463 million 
people globally,1 the corresponding number 
for depression being over 300 million.2 
Diabetes attributed to 5 million deaths in 2017 
while depression was the leading cause for 
suicide globally.2 3 In addition, being global 
health burdens, diabetes and depression 
affect the individuals suffering from the disor-
ders in several ways, with impact on physical 
and mental health and overall well- being.4–6
Diabetes is strongly associated with both 
depression and poorer quality of life.7 Poorer 
quality of life and non- optimal mental health 
can influence diabetes care negatively, predis-
posing to worse glycemic control and an 
increased risk for diabetes- associated compli-
cations.4 According to a recent meta- analysis, 
individuals with diabetes were around 30% 
more likely to develop depression than indi-
viduals with normoglycemia (NGT).8 Some 
studies have reported no association between 
pre- diabetic and depressive symptoms, 
suggesting that depression stems more from 
the burden of diabetes than from insulin 
resistance, which is a characteristic feature of 
Significance of this study
What is already known about this subject?
 ► Diabetes and depression are widespread diseases 
on the rise with a considerable negative influence on 
health- related quality of life.
What are the new findings?
 ► In addition to contributing to the perception that 
previously known diabetes is associated with 
poorer health- related quality of life, we found that 
decreased health- related quality of life is seen in 
subjects with non- melancholic depressive symp-
toms regardless of glucose regulation status.
How might these results change the focus of 
research or clinical practice?
 ► These results highlight the importance of maintain-
ing mental health in individuals suffering from dia-
betes to prevent health- related quality of life from 
deteriorating, further our findings promote more re-
search aiming at characterizing type of depressive 
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the pre- diabetic states.9 10 Furthermore, compared with 
newly diagnosed diabetes, previously diagnosed diabetes 
has been more closely linked to both depression and 
poorer quality of life.8
Metabolic syndrome is characterized by disturbances in 
glucose and lipid metabolism as well as adiposity and is a 
major risk factor for the development of type 2 diabetes. 
Studies have reported a linkage between metabolic 
syndrome and subgroups of depression, that is, mainly 
for non- melancholic and melancholic depression, and 
metabolic syndrome.11–13 Non- melancholic depression is 
characterized by hypersomnia and weight gain, whereas 
melancholic depression is linked with loss of appetite 
and disturbances in affect and psychomotor functions.14 
Non- melancholic depression has been proposed to show 
a stronger association with inflammatory diseases, while 
melancholic depression mainly is a disease of the central 
nervous system not associated with systemic processes.14 15
Although the link between type 2 diabetes and depres-
sion has been studied, less is known about the type of 
depression associated with different degrees of impair-
ment in glucose regulation. Furthermore, only few studies 
have focused on the relationship between pre- diabetes 
and health- related quality of life (HRQoL). Previous 
studies have reported that previously known diabetes is 
associated with poorer physical and mental components 
of HRQoL.4 5 16 Only a few studies have investigated the 
relationship between pre- diabetes and HRQoL, and the 
findings have been inconsistent.17–19
The aim of this study was to investigate whether the 
association between the different degrees of impairment 
in glucose regulation and HRQoL is modified by the 
severity and type of depressive symptoms.
RESEARCH DESIGN AND METHODS
Participants
The Helsinki Birth Cohort Study (HBCS) includes 13 345 
individuals born between 1934 and 1944 at the Helsinki 
University Central Hospital or the Helsinki City Mater-
nity Hospital.20 They attended child welfare clinics 
in Helsinki and were living in Finland in 1971 when a 
unique personal identification number was allocated to 
all individuals of the Finnish population.21 A baseline 
clinical examination was conducted between 2001 and 
2004, involving 2003 cohort members. Of those, 1999 
had sufficient data on glucose regulation status and were 
included in this study. After excluding individuals with 
missing information, 1939 had sufficient information on 
depressive symptoms and 1930 on HRQoL (figure 1).
Glucose regulation
The WHO 2006 criteria22 were used for diagnosing 
diabetes, impaired glucose tolerance (IGT), and 
impaired fasting glucose (IFG). Fasting plasma glucose 
was measured in all individuals participating in the clin-
ical examination and a standard 2- hour 75 g oral glucose 
tolerance test (OGTT) was conducted, except for those 
with previously known diabetes. Previously known 
diabetes was defined by self- report, register linkage, or 
use of medication for diabetes. Individuals who received 
a diagnosis of diabetes for the first time based on the 
OGTT were classified as having newly diagnosed diabetes. 
Individuals who met the criteria for both IFG and IGT 
were classified as having IGT. IFG or IGT were grouped 
together and called pre- diabetes.
Health-related quality of life
HRQoL was assessed using the validated Finnish 36- Item 
Short Form Health Survey (SF-36) version 1.0 question-
naire.23 The average age at the time of filling the ques-
tionnaire was 61.5 years (SD 2.9). The SF-36 consists 
of eight domains: physical functioning (10 items), role 
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limitations caused by physical health problems (four 
items), role limitations caused by emotional health prob-
lems (three items), bodily pain (two items), general 
health (five items), vitality (four items), mental health 
(five items), and social functioning (two items). Possible 
scores for each item ranged from 0 (lowest perceived 
functioning) to 100 (highest perceived functioning). 
Physical and mental health component scores were 
aggregated using the US reference population (1990) to 
standardize the eight domains and for factor score coef-
ficients. The summary scores were standardized using a 
mean of 50 and a SD of 10. The Finnish SF-36 has been 
reported as reliable and well validated.24
Depression
Depression was screened for using the validated 21- item 
Beck’s Depression Inventory (BDI) questionnaire. The 
psychometric properties of the Finnish BDI have been 
well validated.25 26 Patients who scored 10 or higher 
were considered to suffer from depression, as previ-
ously suggested.27 Participants with a BDI score ≥10 were 
divided into melancholic and non- melancholic types 
of depression28 based on the Diagnostic and Statistical 
Manual of Mental Disorders, fourth edition criteria. 
Melancholic symptoms in the BDI (sadness, past failure, 
loss of pleasure, feelings of guilt, punishment feelings, 
loss of interest, irritability, change of sleeping, and appe-
tite) were applied to divide the participants into melan-
cholic and non- melancholic types of depression.12 29–31
Covariates
At the clinical examination, subjects were asked about 
their current health situation, use of medication, and life-
style characteristics. Socioeconomic status was obtained 
from Statistics Finland and was coded as high official, low 
official, self- employed, and laborer based on the orig-
inal classification system.32 Smoking was coded as never, 
former, and current, and alcohol use was coded as never 
or having quit, less than once a week, or weekly. Anthro-
pometrics including weight and height were measured 
and body mass index (BMI) was calculated as weight in 
kilograms divided with height in meters squared. At the 
clinical examination, performed by three trained study 
nurses, the cohort members were asked about their past 
12- month leisure- time physical activity using a validated 
exercise questionnaire: the Kuopio Ischemic Heart 
Disease Risk Factor Study.33 Leisure- time physical activity 
was measured in metabolic equivalents of task (MET),34 
which were multiplied with time (hours) and frequency 
to calculate MET- hours as previously suggested.35 Cohort 
members were also asked about chronic diseases and 
conditions, including cardiovascular conditions (conges-
tive heart failure, arrhythmias, claudication, angina 
pectoris, previous heart attack, and stroke), lung diseases 
(asthma, emphysema, and chronic bronchitis), muscu-
loskeletal disorders (rheumatoid arthritis, osteoporosis) 
and presence of cancer using validated questionnaires. 
The presence of comorbidities was coded as none, one, 
two, or more.
Statistical analysis
Characteristics of the cohort members were compared 
across glucose regulation groups using general linear 
models. In the case of violation (eg, non- normal distri-
bution), a bootstrap- type analysis with 2500 replications 
was used. General linear models were also applied to 
investigate the associations between glucose regulation 
status and physical functioning, mental functioning, and 
depressive symptoms. Adjustments were first made for 
sex and age, then for lifestyle factors (smoking status, 
alcohol consumption, socioeconomic status, leisure- time 
physical activity, and comorbidities), and lastly for BMI 
as our early models showed a relatively strong effect by 
BMI when controlling for it. All tests were performed 
two- tailed and the level of significance was set at p<0.05. 
Statistical analyses were carried out using Stata Version/
MP V.15.1 (Stata, College Station, Texas, USA) and IBM 
SPSS Statistics V.25 (IBM, Armonk, New York, USA).
RESULTS
Participants’ characteristics
This study included 897 men and 1042 women. The mean 
age at the time of the clinical examination was 61.5 years for 
both sexes (SD 2.8 for men and 3.0 for women). The char-
acteristics of the cohort members across the glucose regu-
lation groups—that is, NGT, pre- diabetes, newly diagnosed 
diabetes, and previously known diabetes—are shown in 
table 1.
Subgroups of glucose regulation and HRQoL and BDI
As described in table 2, in the HRQoL subscales, previously 
known diabetes was associated with lower physical func-
tioning, general health, vitality, social functioning, and PCS 
after the model was fully adjusted for covariates. In addition, 
we detected a significant (p<0.02) association between the 
physical and emotional role limitations and bodily pain after 
adjusting for sex, age, smoking status, alcohol consump-
tion, socioeconomic status, leisure- time physical activity, and 
comorbidities in patients with previously known diabetes. 
However, these associations attenuated after further adjusting 
for BMI (p>0.073). Previously known diabetes was also associ-
ated with higher BDI score (table 2).
HRQoL according to types of depressive symptoms across 
glucose regulation subgroups
Both non- melancholic and melancholic depressive symp-
toms were associated with lower Physical Component Score 
(PCS) and Mental Component Score (MCS) compared with 
those with a BDI score <10 regardless of glucose regulation 
status (table 3 and figure 2). No significant interaction was 
detected between the different groups of impairment in 
glucose regulation and type of depressive symptoms on the 
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P- values for between- group 
comparison
Model 1 Model 2 Model 3
HRQoL
  Physical functioning 85.0 (16.8) 82.3 (18.2) 80.1 (17.5) 71.4 (23.1) <0.001 <0.001 <0.001
  General health 66.4 (18.1) 63.8 (17.9) 60.1 (18.5) 51.7 (17.8) <0.001 <0.001 <0.001
  Vitality 71.8 (18.9) 70.4 (19.2) 70.3 (20.8) 64.4 (20.7) <0.001 0.001 0.012
  Mental health 81.9 (14.4) 80.6 (15.0) 81.6 (15.7) 79.8 (17.2) 0.086 0.099 0.160
  Physical role limitations 82.6 (30.6) 80.7 (33.0) 78.3 (34.6) 72.2 (36.4) 0.001 0.020 0.459
  Emotional role limitations 85.1 (28.4) 84.2 (31.2) 81.8 (32.3) 75.4 (36.3) 0.001 0.007 0.073
  Social functioning 90.2 (17.9) 90.0 (16.8) 90.3 (16.6) 83.5 (21.1) <0.001 0.001 0.007
  Bodily pain 78.6 (22.0) 78.6 (22.4) 77.9 (21.8) 70.6 (25.7) <0.001 0.012 0.070
  PCS 49.0 (8.5) 48.2 (8.7) 47.0 (8.1) 43.2 (10.0) <0.001 <0.001 0.001
  MCS 54.2 (8.7) 53.9 (8.9) 54.3 (9.0) 52.9 (10.8) 0.267 0.231 0.189
  BDI 5.4 (4.9) 5.9 (5.1) 5.8 (5.9) 7.4 (5.7) <0.001 0.001 0.015
Data are shown as mean (SD). Model 1 adjusted for age and sex. Model 2 adjusted for Model 1+smoking, alcohol usage, socioeconomic 
status, comorbidities, and leisure- time physical activity. Model 3 adjusted for Model 2+body mass index.
Pre- diabetes = impaired fasting glucose and impaired glucose tolerance,
Newly diagnosed diabetes = diabetes diagnosed with the OGTT at clinical examination in 2001-2004; Previously known diabetes = diabetes 
diagnosed before the clinical examination in 2001–2004.
BDI, Beck’s Depression Inventory; HRQoL, health- related quality of life; MCS, Mental Component Score; NGT, normal glucose tolerance; 
PCS, Physical Component Score.









P- values for between- group comparison
Model 1 Model 2 Model 3
Normal glucose tolerance (n=1005)
  n 839 110 56
  PCS 50.0 (7.6) 42.8 (10.1) 46.2 (10.7) <0.001 <0.001 <0.001
  MCS 56.4 (6.1) 43.3 (11.9) 44.0 (11.1) <0.001 <0.001 <0.001
Pre- diabetes (n=610)
  n 483 85 42
  PCS 49.4 (8.1) 43.0 (9.7) 44.9 (9) <0.001 <0.001 <0.001
  MCS 56.5 (5.7) 42.2 (11) 47.6 (11.4) <0.001 <0.001 <0.001
Newly diagnosed diabetes (n=181)
  n 144 28 9
  PCS 48.1 (7.4) 42.0 (10) 44.2 (6.6) 0.003 0.005 0.015
  MCS 57.1 (6.2) 43.5 (10.5) 43.6 (10) <0.001 <0.001 <0.001
Previously known diabetes (n=134)
  n 98 27 9
  PCS 44.7 (9.3) 37.4 (11.2) 44.3 (9.1) 0.006 0.014 0.064
  MCS 56.1 (6.6) 45.5 (14.2) 40.5 (16.2) <0.001 <0.001 <0.001
Data are shown as mean (SD). Model 1: adjusted for age and sex. Model 2: adjusted for Model 1+smoking, alcohol usage, socioeconomic 
status, comorbidities and leisure- time physical activity. Model 3: adjusted for model 2+body mass index.
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CONCLUSIONS
Our findings showed no interaction between impairment 
in glucose regulation and type of depressive symptoms 
on HRQoL. However, both types of depressive symp-
toms had a stronger influence on the mental compo-
nent of HRQoL than on the physical component. This 
association was detected regardless of impairment in 
glucose regulation. We also found that non- melancholic 
depressive symptoms were associated with lower physical 
quality of life in all subjects regardless of glucose regu-
lation status. Based on these findings, it seems that type 
of depressive symptoms does not modify the association 
between glucose regulation and HRQoL.
Previously known diabetes was associated with higher 
BDI scores, which is consistent with previous findings.7 8 36 
No association was detected between pre- diabetes and 
newly diagnosed diabetes and BDI score. Other studies 
have also been unable to find an association between 
depression and pre- diabetes and newly diagnosed 
diabetes.37 38 It has previously been suggested that the 
burden of diabetes as a disease is responsible for the 
decline in mental health among people with diabetes, 
which could explain our findings as they indicate that 
pre- diabetes is not linked with depressive symptoms nor 
poorer mental functioning.39
We found that HRQoL was lower among subjects with 
previously known diabetes, but not among those with 
pre- diabetes and newly diagnosed diabetes. In line with 
our findings, it has been suggested that longer duration 
of diabetes, but not pre- diabetes, is related to decreased 
HRQoL.4 5 16 Decreased HRQoL related to years of living 
with diabetes may be attributed to higher prevalence of 
comorbidities and complications, such as neuropathy 
and retinopathy that have been associated with lower 
HRQoL.40 41 Unfortunately, we were unable to adjust 
for specific diabetes complications, which might affect 
our findings. The PCS was lower among subjects with 
previously known diabetes compared with the other 
subgroups. Despite this, previously known diabetes was 
not associated with a decrease in the physical role limita-
tions domain nor with the bodily pain domain of the 
SF-36 score. Physical inactivity and obesity affect physical 
performance, and both are known risk factors for devel-
oping diabetes42; however, even after adjusting for them, 
there was a significant association between impaired 
glucose regulation and poorer physical functioning. 
According to our adjusted models, BMI strongly affects 
the associations between diabetes and poorer HRQoL.
As expected, both types of depression lowered MCS 
more than the PCS in all subgroups of glucose regula-
tion. Subjects with symptoms of non- melancholic depres-
sion were associated with lower physical HRQoL than 
subjects with BDI score <10 or symptoms of melancholic 
depression. This association was independent of diabetes 
status, although most clearly seen in subjects with NGT 
and previously known diabetes. This is to the best of 
our knowledge the first study with the aim to investigate 
whether type of depressive symptoms affects HRQoL 
Figure 2 Adjusted differences of non- melancholic and melancholic depression types from the Beck’s Depression Inventory 
(BDI) <10 group in the Physical Component Score (PCS) and Mental Component Score (MCS) of health- related quality of life 
(HRQoL) among subgroups of glucose regulation. Analyses are adjusted for sex, age, smoking status, alcohol consumption, 
socioeconomic status, leisure- time physical activity, comorbidities, and body mass index. Error bars indicate 95% CIs. ; 
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among the diabetic population. According to previous 
studies, non- melancholic depressive symptoms have 
been found to associate with elevated fasting glucose 
and IGT13 as well as with metabolic and inflammatory 
conditions,12 14 and has been suggested to originate 
from a systemic inflammation in the organism, whereas 
melancholic depression is thought to be purely a product 
of imbalances in the function of the central nervous 
system.14 15 43 This theory suggests that non- melancholic 
depression shares a common underlying denominator 
with other systemic diseases, such as diabetes, which our 
findings support.
Our study has several strengths. The cohort is well char-
acterized, and our results were produced using both clin-
ical and registered- based data. We were able to control 
for several factors known to influence both prevalence 
of depression and HRQoL. We used an OGTT to assess 
glucose regulation status, the validated SF-36 for assessing 
HRQoL, and the standardized BDI questionnaire for 
assessing depression. We used the summary scores of the 
SF-36 as well as the component scores. The study also has 
some limitations. Our study sample is from a homoge-
neous, restricted area in Finland and the findings from 
this study might therefore have to be cautiously imple-
mented in other populations. As a result, the sample 
selected may not be representative of the entire Finnish 
population and the findings may not be generalized to 
represent the Finnish population. Although our sample 
is large when it comes to glucose regulation status, we 
may have limited power to investigate association related 
to the non- melancholic depressive symptoms. Due to 
the cross- sectional study design, we were unable to assess 
causal relationships. Lastly, although we did take in 
consideration comorbidities, we were unable to adjust for 
complications of diabetes.
In conclusion, both the non- melancholic and melan-
cholic type of depressive symptoms affect mental 
HRQoL more severely than physical HRQoL regard-
less of impairment in glucose regulation. Symptoms of 
non- melancholic depression are associated with lower 
physical HRQoL in all subjects, especially in normogly-
cemic subjects and in subjects with previously known 
diabetes. Thus, our findings support the necessity of 
preventing pre- diabetes from turning into diabetes and 
identifying the type of depression to maintain high 
HRQoL. Resources should also be focused on preventing 
a decline in HRQoL and mental health in all stages of 
impaired glucose regulation. Further research is needed 
to investigate the association between diabetes and non- 
melancholic depressive symptoms.
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